BioNTech SE logo
BioNTech SE BNTX
$ 114.13 0.55%

Annual report 2023
added 12-14-2024

report update icon

BioNTech SE Balance Sheet 2011-2024 | BNTX

Annual Balance Sheet BioNTech SE

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- -973 M - -357 M -122 M -277 M - - - - -

Long Term Debt

- - - 231 M - - - - - - - - -

Long Term Debt Current

28.1 M 36 M 27.9 M 6.1 M 3.48 M 2.13 M - - - - - - -

Total Non Current Liabilities

- - - 341 M 166 M 260 M 264 M 301 M - - - - -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

2.76 B 3.22 B 3.94 B 947 M 304 M 386 M 423 M 358 M - - - - -

Deferred Revenue

- - - 300 M 93.6 M 66 M 77.3 M 33.5 M - - - - -

Retained Earnings

- - - -410 M -425 M -246 M -198 M -112 M - - - - -

Total Assets

23 B 23.3 B 15.8 B 2.32 B 798 M 653 M 375 M 390 M - - - - -

Cash and Cash Equivalents

11.7 B 13.9 B 1.69 B 1.21 B 519 M 411 M 172 M - - - - - -

Book Value

20.2 B 20.1 B 11.9 B 1.37 B 493 M 267 M -48.2 M 31.9 M - - - - -

Total Shareholders Equity

- - - 1.37 B 493 M 267 M -48.2 M - - - - - -

All numbers in EUR currency

Quarterly Balance Sheet BioNTech SE

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 154 M - - - 78.1 M - - - 54.1 M - - - 48.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 456 M - - - 341 M - - - 166 M - - - 260 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 3.94 B - - - 947 M - - - 304 M - - - 386 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - 9.88 B - - - -410 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 15.8 B - - - 2.32 B - - - 798 M - - - 653 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 1.69 B - - - 1.21 B - - - 519 M - - - 412 M - - - 172 M - - - 304 M - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 11.9 B - - - 1.37 B - - - 493 M - - - 267 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 11.9 B - - - 1.37 B - - - 494 M - - - 267 M - - - -48.2 M - - - 31.9 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency